These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 2481787

  • 21. Effect of bucindolol on plasma HDL cholesterol subfractions and other plasma lipids in essential hypertensive patients.
    Lehtonen A, Tanskanen A, Temmerman J.
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):448-51. PubMed ID: 2888737
    [Abstract] [Full Text] [Related]

  • 22. [Effects of high-carbohydrate/low-fat diet on serum lipid ratios in healthy young subjects].
    Gan CF, Gong RR, Lin J, Li ZK, Tang H, Huang X, Li RH, Fang DZ.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):267-71, 275. PubMed ID: 18630700
    [Abstract] [Full Text] [Related]

  • 23. [Antihypertensive therapy and modification of metabolic risk factors (glucose and lipid metabolism)].
    Klein W.
    Z Kardiol; 1992 Jun; 81(6):295-302. PubMed ID: 1353932
    [Abstract] [Full Text] [Related]

  • 24. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T, Lehtonen A.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [Abstract] [Full Text] [Related]

  • 25. Effects of different beta-receptor antagonists on handgrip in essential hypertension.
    Fogari R, Marchesi E, Bellomo G, Parini A, Corradi L.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):551-3. PubMed ID: 6129200
    [Abstract] [Full Text] [Related]

  • 26. [Effects of terazosine and atenolol on serum lipids in essential hypertension].
    Bur A, Woisetschläger C, Herkner H, Derhaschnig U, Quehenberger P, Hirschl MM.
    Z Kardiol; 2002 Sep; 91(9):685-92. PubMed ID: 12448067
    [Abstract] [Full Text] [Related]

  • 27. [Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia].
    Pristautz H, Stradner F.
    Wien Med Wochenschr; 1986 Sep 15; 136(17):443-8. PubMed ID: 2879389
    [Abstract] [Full Text] [Related]

  • 28. [Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives].
    Rouffy J, Chanu B, Bakir R, Sauvanet JP.
    J Pharmacol; 1983 Sep 15; 14 Suppl 2():183-99. PubMed ID: 6138467
    [Abstract] [Full Text] [Related]

  • 29. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989 Sep 15; 11(2):247-57. PubMed ID: 2736571
    [Abstract] [Full Text] [Related]

  • 30. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M, Richter WO, Schwandt P, Holzgreve H.
    Int J Clin Pharmacol Ther; 1997 Jun 15; 35(6):231-4. PubMed ID: 9208337
    [Abstract] [Full Text] [Related]

  • 31. A comparison of the hypotensive and metabolic effects of 50 and 100 mg atenolol per day.
    Lithell H, Aberg H, Selinus I.
    Drugs Exp Clin Res; 1986 Jun 15; 12(5):393-6. PubMed ID: 3720523
    [Abstract] [Full Text] [Related]

  • 32. The effect on HDL cholesterol of oxprenolol and atenolol.
    Kjeldsen SE, Eide I, Leren P, Foss OP, Holme I, Eriksen IL.
    Scand J Clin Lab Invest; 1982 Sep 15; 42(5):449-53. PubMed ID: 6130595
    [Abstract] [Full Text] [Related]

  • 33. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A.
    Blood Press Suppl; 1995 Sep 15; 3():38-46. PubMed ID: 8535541
    [Abstract] [Full Text] [Related]

  • 34. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy.
    Nikolaos T, Stylianos G, Chryssoula N, Irini P, Christos M, Dimitrios T, Konstantinos P, Antonis T.
    Med Sci Monit; 2004 Apr 15; 10(4):MT50-2. PubMed ID: 15039653
    [Abstract] [Full Text] [Related]

  • 35. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
    Franz IW, Wiewel D.
    J Cardiovasc Pharmacol; 1984 Apr 15; 6 Suppl 7():S1037-42. PubMed ID: 6085363
    [Abstract] [Full Text] [Related]

  • 36. Effect of mepindolol on serum lipids.
    Martignoni A, Perani G, Finardi G, Mastropasqua E, Fogari R.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov 15; 20(11):543-5. PubMed ID: 7174157
    [Abstract] [Full Text] [Related]

  • 37. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.
    Chin Med J (Engl); 2004 Feb 15; 117(2):163-7. PubMed ID: 14975195
    [Abstract] [Full Text] [Related]

  • 38. Prognostic value of lipoprotein fractions in essential hypertension.
    Verdecchia P, Reboldi G, Angeli F, Gattobigio R, Borgioni C, Filippucci L, Poeta F, Porcellati C.
    Blood Press; 2004 Feb 15; 13(5):295-303. PubMed ID: 15545153
    [Abstract] [Full Text] [Related]

  • 39. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
    El ayachi M, Mziwira M, Vincent S, Defoort C, Portugal H, Lairon D, Belahsen R.
    Eur J Clin Nutr; 2005 Dec 15; 59(12):1379-86. PubMed ID: 16118656
    [Abstract] [Full Text] [Related]

  • 40. Effects of moduretic on plasma lipid and lipoprotein levels in hypertensive African patients.
    Ahaneku JE, Taylor GO, Agbedana OE, Walker O, Salako LA.
    Tokai J Exp Clin Med; 1993 Dec 15; 18(3-6):155-60. PubMed ID: 7701530
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.